Government Owned Invention Available for Licensing, 1793 [06-214]

Download as PDF Federal Register / Vol. 71, No. 7 / Wednesday, January 11, 2006 / Notices Affected Public: Individuals or Households and Business or Other forProfit. Estimated Annual Burden: 1,200 hours. Estimated Average Burden Per Respondent: 10 minutes. Frequency of Response: On occasion. Estimated Number of Respondents: 7,200. Number of Responses Annually: 2400. Dated: December 28, 2005. By direction of the Secretary. Denise McLamb, Program Analyst, Records Management Service. [FR Doc. E6–131 Filed 1–10–06; 8:45 am] rmajette on PROD1PC71 with NOTICES BILLING CODE 8320–01–P VerDate Aug<31>2005 14:20 Jan 10, 2006 Jkt 208001 DEPARTMENT OF VETERANS AFFAIRS Office of Research and Development Government Owned Invention Available for Licensing Office of Research and Development, VA. ACTION: Notice of Government owned invention available for licensing. AGENCY: SUMMARY: The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs, and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or Cooperative Research and Development Agreements (CRADA) Collaboration under 15 U.S.C. 3710a to achieve expeditious commercialization of results of federally funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Technical and licensing information on PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 1793 the invention may be obtained by writing to: Amy E. Centanni, Department of Veterans Affairs, Director, Technology Transfer Program, Office of Research and Development, 810 Vermont Avenue, NW., Washington, DC 20420; fax: 202–254– 0473; e-mail at amy.centanni@mail.va.gov. Any request for information should include the Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231. The invention available for licensing is: SUPPLEMENTARY INFORMATION: U.S. Patent No. 6,770,622 ‘‘NTerminally Truncated Galectin-3 for use in Treating Cancer.’’ Dated: December 27, 2005. Gordon H. Mansfield, Deputy Secretary of Veterans Affairs. [FR Doc. 06–214 Filed 1–10–06; 8:45 am] BILLING CODE 8320–01–M E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 71, Number 7 (Wednesday, January 11, 2006)]
[Notices]
[Page 1793]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-214]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS

Office of Research and Development


Government Owned Invention Available for Licensing

AGENCY: Office of Research and Development, VA.

ACTION: Notice of Government owned invention available for licensing.

-----------------------------------------------------------------------

SUMMARY: The invention listed below is owned by the U.S. Government as 
represented by the Department of Veterans Affairs, and is available for 
licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or 
Cooperative Research and Development Agreements (CRADA) Collaboration 
under 15 U.S.C. 3710a to achieve expeditious commercialization of 
results of federally funded research and development. Foreign patents 
are filed on selected inventions to extend market coverage for U.S. 
companies and may also be available for licensing.

FOR FURTHER INFORMATION CONTACT: Technical and licensing information on 
the invention may be obtained by writing to: Amy E. Centanni, 
Department of Veterans Affairs, Director, Technology Transfer Program, 
Office of Research and Development, 810 Vermont Avenue, NW., 
Washington, DC 20420; fax: 202-254-0473; e-mail at 
amy.centanni@mail.va.gov. Any request for information should include 
the Number and Title for the relevant invention as indicated below. 
Issued patents may be obtained from the Commissioner of Patents, U.S. 
Patent and Trademark Office, Washington, DC 20231.

SUPPLEMENTARY INFORMATION: The invention available for licensing is:

U.S. Patent No. 6,770,622 ``N-Terminally Truncated Galectin-3 for use 
in Treating Cancer.''

    Dated: December 27, 2005.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. 06-214 Filed 1-10-06; 8:45 am]
BILLING CODE 8320-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.